San Diego, CA, United States of America

Mercedes Delgado

This inventor holds 8 USPTO granted patents and 1 published patent application, plus 1 CIPO patent and 1 EPO patent. Top assignee: Signal Pharmaceuticals, Inc.. Active years: 2012-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Mercedes Delgado. Retrieved from https://idiyas.com/inventor/mercedes-delgado

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 8 

% Patents Active = 100.0

 

 

Average Co-Inventor Count = 14.5

ph-index = 4

Forward Citations = 74(Granted Patents)


Company Filing History:


Years Active: 2012-2024

Loading Chart...
Loading Chart...
Loading Chart...
8 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Mercedes Delgado

Introduction

Mercedes Delgado is a prominent inventor based in San Diego, CA. She has made significant contributions to the field of pharmaceuticals, holding a total of 8 patents. Her work focuses on developing novel compounds that have the potential to improve treatment methods.

Latest Patents

Among her latest patents is the invention titled "Substituted diaminocarboxamide and diaminocarbonitrile pyrimidines, compositions thereof, and methods of treatment therewith." This patent provides detailed information about Diaminopyrimidine Compounds, showcasing her innovative approach to pharmaceutical development.

Career Highlights

Mercedes Delgado is currently employed at Signal Pharmaceuticals, Inc., where she continues to push the boundaries of pharmaceutical research. Her expertise and dedication have positioned her as a key player in her field.

Collaborations

Throughout her career, Mercedes has collaborated with notable colleagues, including Jan Elsner and Paul E Erdman. These partnerships have further enhanced her research and development efforts.

Conclusion

Mercedes Delgado's contributions to the field of pharmaceuticals through her innovative patents and collaborations highlight her importance as an inventor. Her work continues to pave the way for advancements in treatment methodologies.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…